Financial statements Accupharma
Balance sheet data of ACCUPHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|
| Total assets | 14 457 839,56 | 8 916 802,48 | 8 886 042,89 | 8 877 121,75 | 8 998 199,01 |
| A. Fixed assets | 5 508 257,23 | 8 848 319,32 | 8 848 319,32 | 8 848 319,32 | 8 848 319,32 |
| B. Current assets | 8 949 582,33 | 68 483,16 | 37 723,57 | 28 802,43 | 149 879,69 |
| C. Share capital contributions (basic funds) | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - |
| Total liabilities | 14 457 839,56 | 8 916 802,48 | 8 886 042,89 | 8 877 121,75 | 8 998 199,01 |
| A. Equity | 831 173,54 | -236 279,60 | 1 073 700,28 | 1 066 868,57 | 1 173 488,21 |
| B. Liabilities and provisions for liabilities | 13 626 666,02 | 9 153 082,08 | 7 812 342,61 | 7 810 253,18 | 7 824 710,80 |
| I. Long-term liabilities | - | 4 618 122,84 | 4 618 122,84 | 4 618 122,84 | 4 618 122,84 |
| II. Short-term liabilities | 10 382 039,25 | 4 534 959,24 | 3 194 219,77 | 3 192 130,34 | 3 206 587,96 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.